Reddit Posts
$NVO for ER run up on ATHs & low IV (reports Wednesday morning)
While the FSR and BOWL guys try to pump their flat tires, OMGA up 15% today
Congratulations to those who listened to me on CYTK. Ultra super duper RIP to shorts there. Rolled my profits into OMGA
Reminder that if you are a PTON, NVO, or LLY bull you have a duty as a shareholder to demotivate all the new people at the gym
$KO outperforms half of the Mag 7 in 2024 because of $NVO and $LLY
Except NVO has started a red revolution with my 105 calls, it's bad!
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real-world study says
Novo Nordisk Semaglutide/cardiovascular outcomes SELECT Trial Results (NVO + see also LLY)
Small account growth over October. SEDG, ENPH, LMT, SPY, NVO.
7 Diabetes and Weight Loss Drug Stocks With Big Potential
Wall Street hikes forecasts for anti-obesity drug sales to $100B and beyond.
I’m starting to learn how to invest in stocks, is my investing plan good?
Novo Nordisk buys hypertension drug in $1.3 Billion Deal
Eli Lilly stock hits new 52-week high amid Ozempic study news
NVO YOLO update - 21k to 70k. I sold some NVO and bought some LLY, details inside
Has $NVO made fat chicks with cute faces the most undervalued investment on the planet?
When do I see the other half of a 1:2 split in my brokerage account
What are your thoughts about Weight Watchers (WW)? I prescribe weight loss medications, and they are very good. WW could be primed.
Is this the end for Novo Nordisk? - $NVO
How does WSB like NVO (Novo Nordisk, makers of Ozempic)?
Is Novo Nordisk (NVO) going to develope anti-obesity semaglutide or put it on the shelf?
2023-04-25 Wrinkle Brain Plays - In the style of a Weather Girl
Why don’t I ever hear anyone talking about Novo Nordisk (NVO)? Huge growth over the last 5 years (268%)
What do you guys think about the high PEs of pharmaceuticals like NVO and LLY?
NVO has majority market share for obesity care which has TAM 50x from current market. Why are calls so cheap ? 20k YOLO inside
Kindly help me narrow down my healthcare stock picks (info in description)
Novo Nordisk to bring down insulin prices by up to 75% (NYSE:NVO)
New weight loss therapies can burden Medicare - experts (NYSE:NVO)
Wegovy CV risk reduction data in obesity could help both Novo Nordisk and Eli Lilly (NVO)
NVO -> 100x easier to lose weight than PTON, but 20x the cost
I had a weird feeling about this deal $NVO & buyout of $DRNA I might exercise my December put options. Anyone here in Dicerna?
Will $TAK or $NVO make a BO offer for $MIRM?
Fatties rejoice NVO has legal drugs to loose weight
Lots of fatties and NVO has a drug for it that just got approved by FDA, thoughts?
So there's a lot of fat people in USA and NVO has a drug for it which just got FDA green light, thoughts?
$NVO approved by FDA to sell anti-obesity drug! Could be a good one!
NVO just came out with a new anti-obesity drug that in clinical trials lowered participants body weight by 15% 💸
$NVO impact of fda approval of Ozempic for obesity?
Mentions
Well I got double fucked. Lost bunch of money on LLY earnings last week because NVO got the exclusive deal for Wegovy over zepbound through CVS. And then today I got the letter in the mail from my insurance that my zepbound will no longer be covered, only Wegovy. Wegovy is a shit product that makes me feel like garbage. Fuck you CVS I hope your company burns to the ground.
NVO is already dead. Retatrutide, or any of 5-10 better options that are lurking, are just going to bury them.
You have no idea how crowded the GLP1 space is about to become, do you? Or, how much money is made in the US market as compared to the rest of the world? NVO’s GLP1 is already the second best on the market. Even without market restrictions, LLY would be dominating. NVO doesn’t have a 2nd generation GLP1 in development, and the 2nd generation is coming soon. And they will have limited access to the most lucrative (by 10x) market in the world…if their restriction is ever lifted, it will be after the improved GLP1s are approved. They are still vastly overvalued.
Trying to make back 11.5k I lost with 1k. Today I bought palantir puts 90 strike MCD puts 310 strike NVO calls 76 and 77 strike AMD calls 105 strike
They partnered with NVO for long term partnership, that’ll bring in money on guidance for sure. But again who knows, all know is that I am holding shares for a long time and selling calls occasionally.
We've been grinding higher all day and you still holding onto your puts. Anyway. All in NVO even if they have a subpar product. They breaking out.
I don’t actually understand why fintwit is hyping them up so much, there are tons of online telehealth sub out there, I don’t see what’s unique with HIMS, maybe their partnership with NVO? But the other guys already sell LLY stuff so…
When retatrutide comes out it’s gonna destroy NVO just saying
AMD calls 110 strike NVO calls 75 strike try to give me a reasoning for why they wont go up, they seem super udnervalued
HIMs will probably move hard I think calls is the play. News with NVO will boost profits and guidance
F down, CELH up, UPST up, NVO up, Z up, CVNA down, SHOP down, TSLA down
While y'all are investing in bitch ass companies like Meta or Nvdia, Hims are profiting of obesity in AMERICA. calls for HIMS and NVO for their earnings next week.
NVO falls in this category. GLP1 daily tablet is going to replace statin drugs sooner than we think.
Those NVO calls I was telling you about. Up 537% 😤
PLTR has been pumping and just hit ATH, so I am not sure about "less stock monitoring" for that one. It may pump and then a day later a ton of profit takers sell their positions. Maybe NVO, as it's closer to 52 week lows, and had a recent catalyst. They may share the expected revenue increases from the deal, which might take the stock into the $70s. Personally, I would go with HIMS as this is a bigger deal for them with membership (recurring revenue) potentially exploding. But, I would babysit that mofo (and put stop loss orders in). LOL
NVO looks like a good buy right now, anyone already in? Thinking of leaps
I didnt enter AUR. I just bought more UBER in the 60s. This was due to UBER owning 19-25% of AUR. Looking back when these things works out it seems to be the smaller company that shoots up more in these partnerships. Just look at HIMs after their NVO partnership. But Im still up on UBER from buying in the 60s so not that bad of a trade off.
Wouldn't be surprised if HIMS squeezes next week. It's just melting up right now with a 27% short interest and they just partnered with NVO. The ingredients are there for a massive pop.
Are we selling the rip today? I'm up so much on Uber, NVO, Hood etc and not sure what direction it's going next week
If you want a legit play, buy NVO calls for next week. It will continue rocketing into earnings. Source: trust me bro
NVO gets their third big win this week and... stock is also down.
CVS dropping LLY and adding NVO
Weight-loss boost CVS announced two key developments in the hot weight-loss market Thursday, marking a shift from insurers that are ending coverage and employers that have put restrictions on access and coverage. The first development was placing Novo Nordisk's (NVO) blockbuster GLP-1 drug Wegovy as a preferred drug on its formulary, to the exclusion of competitor Eli Lilly's (LLY) Zepbound, for $499 per month. "Now that there’s adequate supply of both of these GLP-1s, CVS Caremark was able to negotiate Wegovy against Zepbound to determine which manufacturer of these clinically similar products could deliver the greatest overall value and lowest net cost for our clients that choose to participate on our standard commercial formularies," a spokesperson told Yahoo Finance in a statement Thursday. Lmao https://finance.yahoo.com/news/cvs-posts-q1-earnings-beat-raises-full-year-guidance-103035785.html
Earnings were solid. NVO News fucked it tho. 
Should have brought NVO calls
NVO is the most undervalued stock in the world, anyone think so
!banbet $NVO $70.00 7d
Today was pretty awesome if not slightly boring. NVO + HIMS pump was a cool addition.
Long NVO short LLY. Same industry, cointegrated pair and you can remove market risk. NVO has huge pipeline.
Sure and how widely your hospital available to everyone in the country? HIMs is a distributor for NVO now that would potentially avoid tariffs and whatever else hikes orangutan can do now.
deal with NVO to sell their weightloss drugs
Wish I had been following HIMS a little more closely. Didn’t know NVO was close to getting to sell Wegovy on the HIMS platform
Had an iron condor on NVO, it jumped out of my spread range. Anyone think it will go back below 65 in the next week or so?
Hims Bulls are now crossing their dicks with NVO Bulls.
If you’re confused about the $HIMS news, it’s also because NVO was supposed to the sue the shit out of them. Instead, they partnered with them…
NVO probably goes down 10% on the News...
The CEO beat NVO’s CEO to death with a lead pipe
Yea bb. I got large NVO position sub $60
sold NVO, pretty nice little pump, prob could have held for longer but who tf knows
NVO back over $100 with earnings bc how tf was is just in the 50s again 
Why NVO boomer shares are saved. Ha! We going back up to LLY valuation ladies and gentlemen. Never doubt the danish
These things like HIMS & NVO deal are the kind of events i can appreciate. Finally something other than potential maybe someday tariff relief
I'm selling NVO at 65
why does HIMS pump 10x as much as NVO
NVO only a sliver up compared to HIMS 
So many fat-ass mfs out there, NVO soon going to the moon
thinking about selling the few NVO shares i hold and throwing it into WOLF, both are trash stocks anyway
Lilly better shit the bed on Thursday so I can dump this pos NVO
NVO calls for earnings on may 7. If probably DCA average in on some 70 calls and just sell when the premiums start to rip on them like a day or 2 before. Hope this helps 
Didn't they not release the tolerability profile? NVO's pipeline is quite poor relative to Lilly. And even Lilly's pipeline pales to Viking's, whose tolerability and efficacy combo looks like it will clearly be best in class and could potentially solve the issue of high discontinuation rates in patients within a year.
What about NVO's Amycretin? It's only phase 1 so far, but if I'm not mistaken, it will leapfrog all other drugs on the market if the trend continues. And it's designed for oral use
Why NVO? I own some as well, but I don't see them growing nearly as big or as fast as NVDA
Yeah, I've been hoping for months for this sort of news to boost my NVO bags... Nope. It's impervious to good news
why 100% on WHR? Surely if you’re going 100% why not something else like apple or google. Shit even NVO. So many other better picks
I agree with your general sentiment, but you are overlooking some companies outside of pure tech. ASML, NVO, LVMH are world dominating in their respective field (NVO sharing the throne). There is simply no competition for ASML. SAP and DTG are second tier, but still critical. BMW sells more cars than Tesla. Tesla is just propped up, and not for business reasons.
And knowing NVO, it's going to tank anyway When are you going to finally rally? Come on buddy, you can do it
Or it means OP needs to take some GLP-1 so he doesn't tilt the elevator enough to mess up the CD Rom that has the boot media. Calls on $NVO
NVO is inching back to green and should be a green dildo next week. $70 calls for friyay
Can't get over NVO dumping after winning in court
Yea. I bought ASML. Looking at putting 1% of portfolio into NVO. There are worst things to do a yolo on.
Can someone, for the love of god, pump NVO, they tanked on a court win.
So NVO decides to tank because compounders can't copy their drug anymore? WTF are these algos doing
Yeah, but doesn't it reduce competition? Or were these 'copies' licensed by NVO. I can't seem to find much info on the specifics.
NVO at PE 14 is a fucking steal especially is allowed to roam around PE 60
There are still sectors out there that havent fully recovered like healthcare (UNH/NVO) and homebuilders. Those could be buys right now but sentiment tends to be against buying stocks near 52 week lows. People might prefer to see a rally in those names before they jump in.
NVO seems to have cancelled the downtrend for now
NVO is a piece of shit
That often happens when stocks are near their 52 week lows. I barely even hear NVO mentioned on this sub these days. MRNA/BNTX if you want to throw in two more with even less positive sentiment than NVO has right now.
NVO is one of the best long term buy and hold opportunities you’ll ever see
What stocks are still substantially down and we can ride this bull up? INTC, NVO, what else?
NVO pumping just cause
NVO is actually the greenest thing in my port
I bought puts on LLY. NVO will never go up again 
Someone explain to me wtf is going on with that pos stock $NVO ?????? Why does it keep going down.
I entered a position in NVO today
each time im telling myself i buy NVO it drops another 10% Yeah cya at 50
how can NVO have a forward pe of 2.3?
NVO seems too cheap, Rybelsus results were not really bad at all and tariff concerns seem unlikely to be significant given they have manufacturing capacity in the NC. Thinking about getting some LEAPs for 2027... I've been fooled before by this stock, but according to an old saying from Tennessee (or possibly Texas) if you are fooled once it is physically impossible to be fooled again. 
NVO, GOOG, ASML, AMZN are all solid plays imo UBER seems cheap still too
Is NVO low enough yet? I'm in at 72 and prolly buying more next week
Jesus NVO beat down the drain im buying calls
It didn't beat Ozempic in weight loss performance from what I read - it's roughly the same The main benefit is that it's far more user friendly (oral dose) and supposedly easier to manufacture at scale (which means more profit) But for pure performance, both LLY's Zepbound and NVO's upcoming CagriSema are even better NVO also has Amycretin, an oral medication in early trial phases that seems super promising - but it's still early days
LLY has US manufacturing. NVO is Danish. Imported. Soon to tariffed(?). LLY is positioned to be cheaper for consumers under tariffs. NVO will see margins compress unless they raise price. The pill variant news is just icing on the cake for LLY.